endocrine-modulating drug therapy

DRUG4 trials

Sponsors

Fred Hutchinson Cancer Center, Pfizer, Memorial Sloan Kettering Cancer Center, SWOG Cancer Research Network

Conditions

Breast CancerOvarian CancerProstate Cancer

Phase 1

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

CompletedNCT00003080

Fred Hutchinson Cancer CenterOvarian Cancer

Start: 1996-09-30End: 2001-05-31Updated: 2010-09-15

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

CompletedNCT00003394

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 1998-04-30End: 2003-04-30Target: 18Updated: 2013-06-24

Phase 3

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

CompletedNCT00003343

PfizerProstate Cancer

Start: 1998-03-31Target: 525Updated: 2012-08-08

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

CompletedNCT00929591

SWOG Cancer Research NetworkBreast Cancer

Start: 1989-05-31End: 2010-03-31Updated: 2013-01-24

Related Papers

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.

2009-12-10169 citations